A custom collaboration with: Quintiles
Immunological Patriots
Nicho Bourque made it a joke at first. She had to. Her dermatologist had biopsied... Read More
From Discovery to Market
The process of developing therapeutics has multiple expense points; spending does not necessarily correlate with output, as historic data will show. View Infographic
Putting Compassion Behind Compounds
Our mission is to serve patients, even ones who don’t have any money, says Richard Chin, chief executive officer of... Read More
The J&J Way
We start where the patients have unmet medical needs, and then try to match that with the science, says Joanne... Read More
Pharma’s Innovation Challenge
Ten years ago, the sequencing of the human genome promised a new golden age of medicine. Thousands of new drug... Read More
The Changing FDA
The U.S. Food and Drug Administration (FDA) shoulders the enormous responsibility of ensuring the safety, efficacy and quality of prescription... Read More
BY THE NUMBERS:
FROM DISCOVERY TO MARKET
The process of developing therapeutics has multiple expense points, which will undoubtedly change as new business models replace old ones. Here is a snapshot of the current major expenditures related to the bench-to-bedside enterprise.
Share
© 2010 Scientific American,
a division of Nature America, Inc.
All Rights Reserved.
www.sa-pathways.com
